Outset Medical Statistics

Total Valuation

Outset Medical has a market cap or net worth of $79.11 million. The enterprise value is $11.41 million.

Market Cap	79.11M
Enterprise Value	11.41M

Important Dates

The next confirmed earnings date is Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Outset Medical has 18.31 million shares outstanding. The number of shares has increased by 339.24% in one year.

Current Share Class	18.31M
Shares Outstanding	18.31M
Shares Change (YoY)	+339.24%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	66.93%
Float	13.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
Forward PS	0.61
PB Ratio	0.62
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.80.

Current Ratio	6.67
Quick Ratio	5.24
Debt / Equity	0.80
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.78

Financial Efficiency

Return on equity (ROE) is -106.20% and return on invested capital (ROIC) is -18.25%.

Return on Equity (ROE)	-106.20%
Return on Assets (ROA)	-15.43%
Return on Invested Capital (ROIC)	-18.25%
Return on Capital Employed (ROCE)	-29.41%
Weighted Average Cost of Capital (WACC)	12.71%
Revenue Per Employee	$385,406
Profits Per Employee	-$263,397
Employee Count	310
Asset Turnover	0.44
Inventory Turnover	1.36

Taxes

In the past 12 months, Outset Medical has paid $718,000 in taxes.

Income Tax	718,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.69% in the last 52 weeks. The beta is 1.96, so Outset Medical's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	-62.69%
50-Day Moving Average	3.77
200-Day Moving Average	8.57
Relative Strength Index (RSI)	55.46
Average Volume (20 Days)	117,963

Short Selling Information

The latest short interest is 2.09 million, so 11.40% of the outstanding shares have been sold short.

Short Interest	2.09M
Short Previous Month	1.95M
Short % of Shares Out	11.40%
Short % of Float	16.01%
Short Ratio (days to cover)	16.31

Income Statement

In the last 12 months, Outset Medical had revenue of $119.48 million and -$81.65 million in losses. Loss per share was -$5.37.

Revenue	119.48M
Gross Profit	46.75M
Operating Income	-66.71M
Pretax Income	-80.94M
Net Income	-81.65M
EBITDA	-62.37M
EBIT	-66.71M
Loss Per Share	-$5.37

Full Income Statement

Balance Sheet

The company has $168.95 million in cash and $101.25 million in debt, giving a net cash position of $67.70 million or $3.70 per share.

Cash & Cash Equivalents	168.95M
Total Debt	101.25M
Net Cash	67.70M
Net Cash Per Share	$3.70
Equity (Book Value)	126.95M
Book Value Per Share	6.99
Working Capital	213.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$46.33 million and capital expenditures -$798,000, giving a free cash flow of -$47.13 million.

Operating Cash Flow	-46.33M
Capital Expenditures	-798,000
Depreciation & Amortization	4.34M
Net Borrowing	-106.68M
Free Cash Flow	-47.13M
FCF Per Share	-$2.57

Full Cash Flow Statement

Margins

Gross margin is 39.13%, with operating and profit margins of -55.84% and -68.34%.

Gross Margin	39.13%
Operating Margin	-55.84%
Pretax Margin	-67.74%
Profit Margin	-68.34%
EBITDA Margin	-52.21%
EBIT Margin	-55.84%
FCF Margin	n/a

Dividends & Yields

Outset Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-339.24%
Shareholder Yield	-339.24%
Earnings Yield	-103.22%
FCF Yield	-59.57%

Analyst Forecast

The average price target for Outset Medical is $13.33, which is 208.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.33
Price Target Difference	208.57%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	11.41%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Mar 20, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Outset Medical has an Altman Z-Score of -4.75 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.75
Piotroski F-Score	5